3B BLACKBIO DX
|
3B BLACKBIO DX Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 34.62 | 42.98 | 152.00 | 10.25 | 8.20 |
| CEPS(Rs) | 35.77 | 43.88 | 152.82 | 10.98 | 9.06 |
| DPS(Rs) | 2.50 | 10.50 | 1.00 | 0.70 | 0.50 |
| Book NAV/Share(Rs) | 228.55 | 204.26 | 176.27 | 42.87 | 35.20 |
| Tax Rate(%) | 26.54 | 25.50 | 25.10 | 23.52 | 24.60 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 47.13 | 46.00 | 66.15 | 32.27 | 31.02 |
| EBIT Margin(%) | 57.42 | 53.73 | 67.15 | 35.97 | 31.85 |
| Pre Tax Margin(%) | 57.10 | 53.60 | 67.05 | 34.81 | 29.86 |
| PAT Margin (%) | 41.94 | 39.93 | 50.22 | 26.62 | 22.52 |
| Cash Profit Margin (%) | 43.34 | 40.76 | 50.49 | 28.48 | 24.87 |
| Performance Ratios | |||||
| ROA(%) | 12.77 | 16.70 | 95.54 | 18.94 | 15.71 |
| ROE(%) | 16.00 | 22.59 | 138.73 | 28.15 | 28.99 |
| ROCE(%) | 21.60 | 29.92 | 179.46 | 32.29 | 28.04 |
| Asset Turnover(x) | 0.30 | 0.42 | 1.90 | 0.71 | 0.70 |
| Sales/Fixed Asset(x) | 4.75 | 7.17 | 23.54 | 3.38 | 2.93 |
| Working Capital/Sales(x) | 0.62 | 1.25 | 3.01 | 0.93 | 1.07 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.21 | 0.14 | 0.04 | 0.30 | 0.34 |
| Receivable days | 188.65 | 146.56 | 44.04 | 242.80 | 274.14 |
| Inventory Days | 45.68 | 27.85 | 7.20 | 57.29 | 67.94 |
| Payable days | 70.42 | 37.45 | 22.43 | 100.56 | 124.67 |
| Valuation Parameters | |||||
| PER(x) | 12.01 | 7.94 | 1.87 | 7.08 | 9.21 |
| PCE(x) | 11.62 | 7.78 | 1.86 | 6.61 | 8.34 |
| Price/Book(x) | 1.82 | 1.67 | 1.62 | 1.69 | 2.14 |
| Yield(%) | 0.60 | 3.08 | 0.35 | 0.96 | 0.66 |
| EV/Net Sales(x) | 4.11 | 2.84 | 0.79 | 1.68 | 2.19 |
| EV/Core EBITDA(x) | 6.99 | 5.21 | 1.18 | 4.44 | 6.41 |
| EV/EBIT(x) | 7.16 | 5.29 | 1.18 | 4.67 | 6.89 |
| EV/CE(x) | 1.19 | 1.19 | 0.93 | 1.08 | 1.41 |
| M Cap / Sales | 5.04 | 3.17 | 0.94 | 1.88 | 2.07 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -23.32 | -64.43 | 685.26 | 24.05 | 0.28 |
| Core EBITDA Growth(%) | -17.34 | -71.22 | 1,300.36 | 37.12 | 39.62 |
| EBIT Growth(%) | -18.05 | -71.54 | 1,366.08 | 40.08 | 41.33 |
| PAT Growth(%) | -19.45 | -71.72 | 1,381.27 | 46.66 | 52.99 |
| EPS Growth(%) | -19.45 | -71.72 | 1,383.24 | 24.95 | 52.80 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.02 | 0.02 | 0.11 | 0.28 |
| Current Ratio(x) | 8.05 | 4.82 | 2.76 | 4.82 | 3.08 |
| Quick Ratio(x) | 7.49 | 4.38 | 2.64 | 4.32 | 2.60 |
| Interest Cover(x) | 178.97 | 407.23 | 666.83 | 31.08 | 16.02 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | 0.01 | 0.06 | 0.13 |
Compare Financial Ratios of peers of 3B BLACKBIO DX
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| 3B BLACKBIO DX | ₹553.0 Cr | -7.7% | -2.5% | 69.2% | Stock Analytics | |
| PI INDUSTRIES | ₹54,559.4 Cr | -4.7% | -7.6% | 7.6% | Stock Analytics | |
| UPL | ₹37,046.2 Cr | -2.9% | 5.8% | -32.6% | Stock Analytics | |
| BAYER CROPSCIENCE | ₹24,560.8 Cr | -1.1% | -1.2% | 31.4% | Stock Analytics | |
| SUMITOMO CHEMICAL INDIA | ₹20,140.5 Cr | -0.2% | 11.5% | -0.5% | Stock Analytics | |
| BASF INDIA | ₹17,595.8 Cr | 9.7% | 13.9% | 69.1% | Stock Analytics | |
3B BLACKBIO DX Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| 3B BLACKBIO DX | -7.7% |
-2.5% |
69.2% |
| SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses
